Services
DiGA (Digital Health Applications)
The focus is on the goal of listing your DiGA (digital health application) and the resulting reimbursement eligibility.
The DiGA process begins in the post-market phase of your CE-marked medical device. We will also be happy to support and advise you on the way to CE marking! (see Regulatory Affairs & QM) You must provide proof of positive care effects (pVE) for your product: “DiGA manufacturers who submit an application for testing must plausibly demonstrate that the DiGA can achieve one or more pVE for a specific patient group .
This requires the submission of a systematic evaluation of data for the use of the DiGA.” (Source: current BfArM guidelines) You can generate the data for the proof in various ways; we will support you in choosing the optimal design. We design the DiGA studies in such a way that the requirements of DGV, DiGAV and guidelines are met, but the clinical data can also be used for clinical evaluation in accordance with the MDR requirements.
![image](https://www.medxteam.de/images/cliparts/diga_en.png)
The provisional listing
- Supporting the concept for systematic data collection as input for the evaluation concept
- Advice and support regarding possible BfArM discussions
- Systematic data evaluation
- Creation of the evaluation concept (including targeted literature research and evaluation in accordance with the BfArM guidelines)
The final listing
- Planning the DiGA study
- Preparation of all required documents in accordance with ISO 14155
- Implementation of the DiGA study including data management and monitoring
- (statistical) evaluation of the study data and creation of the clinical investigation report
-> You can find our offer in the context of clinical investigations here